The safety and efficacy of lung volume reduction surgery: A 25-year single institution experience

Read full text Summarise with VIRAT
Authors: Gian-Marco Monsch, Bianca Battilana, Claudio Caviezel, Dario Gregori, Ester Rosa, A. Yu. Grabar, K. Chiffi, Carolin Steinack, Didier Schneiter, Isabelle Opitz
Cited by: 0
References: 36

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective Lung volume reduction surgery (LVRS) in well-selected patients significantly improves lung function. Regardless of its proven effects, LVRS is still widely underused worldwide. In this overview, we demonstrate our 25 years of experience in the largest single-center cohort. Methods Retrospective analysis of prospectively collected data on patients undergoing LVRS at the Department of Thoracic Surgery, University Hospital Zurich between November 2000 and February 2025 is presented, including functional outcomes. Results Seven hundred thirteen patients (323 women [45.3%]) with a median age of 65 years (range, 59-71 years) and predominantly heterogeneous morphology (70.3%) needing in 38.9% permanent oxygen supply underwent LVRS (93.7% minimally invasive approach, 43.1% bilateral). All relevant lung function parameters had improved significantly at the 6-month follow-up (change [Δ] forced expiratory volume in 1 second: +22.0% predicted, Δ residual volume: –762.2 mL, Δ total lung capacity: –418.1 mL, Δ residual volume to total lung capacity ratio: −10.3%, Δ diffusing capacity of the lungs for carbon monoxide: +3.2, and Δ 6-minute walk distance: +32 m; all P values < .001). The most common postoperative complication was prolonged air leak (27.2%), necessitating redo surgery in 78 (10.9%) patients. In-hospital mortality was 0.7%, and 90-day mortality was 2.1%. The 1- and 5-year survival rates were 93.4% and 52.1%, respectively. Body mass index below 18.5 and higher intraoperative Paco 2 were associated with poorer survival. Conclusions LVRS leads to a significant improvement of all key lung function parameters, with low in-hospital mortality in this very fragile patient cohort.

Fields of Study & Subjects

Chronic Obstructive Pulmonary Disease (COPD) Research Respiratory Support and Mechanisms Transplantation: Methods and Outcomes

Publication details

Journal / source
JTCVS Open
Volume
32
Pages
101722–101722
Publication date
2 April 2026
Language
EN